| 000 | 01655 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515021204.0 | ||
| 264 | 0 | _c20060725 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2006.02.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillard, Michel | |
| 245 | 0 | 0 |
_aBinding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cApr 2006 |
||
| 300 |
_a102-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAzides _xmetabolism |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCerebellum _xmetabolism |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aHippocampus _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPyrrolidines _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aChatelain, Pierre | |
| 700 | 1 | _aFuks, Bruno | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 536 _gno. 1-2 _gp. 102-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2006.02.022 _zAvailable from publisher's website |
| 999 |
_c16164070 _d16164070 |
||